医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Abdominal lymphoma (C85.900x010) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Retroperitoneal lymphoma (C85.900x009) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Pulmonary lymphoma (C85.900x008) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Primary malignancy of lymph nodes/lymphoid tissue; painless progressive node enlargement. Peak 31-40y (NHL earlier). M:F 2-3:1. Unknown cause (genes/viruses/radiation/drugs/autoimmunity). Systemic disease; can involve any tissue.
肿瘤内科Mesenteric lymphoma (C85.900x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Intestinal lymphoma (C85.900x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Tonsillar lymphoma (C85.900x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Nasal lymphoma (C85.900x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Sinonasal lymphoma (C85.900x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
NHL is a major class of malignant lymphoma; far more common than Hodgkin disease in China; incidence rising. Heterogeneous group; complex pathology/clinical/treatment; cure rate lower than HD. Leukemic changes in ~50% pediatric/~20% adult cases.
肿瘤内科Natural-killer/T-cell lymphoma (C85.724) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Intestinal T-cell lymphoma (C85.723) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Primary cutaneous CD30+ T-cell lymphoma (C85.722) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Anaplastic large-cell lymphoma, ALK-positive (C85.721) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Skin-associated lymphoid-tissue (SALT) lymphoma (C85.720) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is be
Bronchus-associated lymphoid-tissue (BALT) lymphoma (C85.719) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction i
Mucosa-associated lymphoid-tissue (MALT) lymphoma (C85.718) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is
Extranodal marginal-zone B-cell lymphoma (C85.717) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being com
Nodal marginal-zone B-cell lymphoma (C85.716) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Angioendotheliomatosis (C85.715) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|
